At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 27 enrolled
Drug / intervention
Omega-3 oils from tri-glycerides +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Correlation Between Level of Polyunsaturated Fatty Acid EPA and DHA in Blood After Digestion of ProBios Omega-3 Concordix™ Compared With Omega-3 Soft Capsules - a Pilot
In Brief
A Phase 1 clinical trial evaluating Omega-3 oils from tri-glycerides and Omega-3 oils from marine phospholipids for Healthy. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the short term absorption of EPA and DHA from triglycerides (TG) released from normal soft gel capsules and from the new patent pending vehicle providing a gastric stable emulsion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesNorway
Collaborators--
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
Primary CompletionJun 2009
First PostedFeb 2010
TodayJul 2026
First PostedFeb 3, 2010
Enrollment StartMar 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.4 years ago
Interventions
Omega-3 oils from tri-glyceridesdietary
Single-dose administration of approximately 5 grams of omega-3 oils from triglycerides
Omega-3 oils from marine phospholipidsdietary
Single-dose administration of approximately 5 grams of omega-3 oils from marine phospholipids